Swedish digi-physical healthcare company Kry has voted to significantly simplify its shareholder structure by reducing the number of categories of shares it has and converting most of its preference shares into ordinary shares.
French pharma giant Sanofi and US PE firm Clayton Dubilier & Rice (CD&R) have been made to sign a promise to the French government to keep factories and jobs in France after the sale of a 50% stake in Sanofi's consumer health division, Opella, to CD&R. Sanofi and CD&R are now in exclusive talks for the sale, in a deal which is valuing Opella at $16.4 billion.
Parkway Life Real Estate Investment Trust (PLife REIT), one of Asia’s largest listed healthcare REITs, has acquired 11 nursing homes in France in a sale and leaseback arrangement for €111.2m (roughly S$159.9 million) from DomusVi, one of Europe’s largest nursing and retirement home providers. The deal marks PLife REIT’s maiden acquisition in Europe, as part of its long-term strategy to grow its presence in the region and the UK.
In this interview Stéphane Carré, CEO of pan-European radiotherapy provider Amethyst Radiotherapy, explains how his company is aiming to increase access to state of the art radiotherapy services, and provide a holistic care journey geared towards making the patient feel as comfortable as possible. Stéphane Carré will be sharing more about his business model at HBI 2025, in Paris, March 24-26, 2025.
AI solutions for healthcare are evolving at pace, and fast-growth Danish startup Corti is no exception. After closing a $60 million Series B funding round last year, the software company says it is now attracting interest from Silicon Valley figures and major tech companies. But what makes it stand out from its competitors? We spoke with Corti’s Chief Strategy and Medical Officer, Frederik Brabant, about how exactly the product is built and works, why it’s making waves, and what its future looks like.
Montefiore Investment, a French private equity firm dedicated to service SMEs and mid-market companies, has announced it has made a binding agreement with Vam Investments for the acquisition of a majority stake in Demenego, a chain of specialised optical centres in North-East Italy.
Europe, especially the UK, is seeing rising private equity interest and larger companies entering the digital health sector. Deal volumes are expected to grow as providers consolidate across the value chain.
The global digital health sector on the whole is increasingly attractive for private equity investments, with experts predicting a surge in M&A deals over the coming months.
On October 11, Reuters reported that Sanofi, the French drugmaker, is negotiating a sale of a 50% stake in its consumer health business, Opella, to US private equity firm Clayton Dubilier & Rice (CD&R). The negotiation is valuing the business at €16.4 billion. This move is part of Sanofi's strategy to separate its consumer healthcare segment to fund new drug development.
Extens, a France-based investment fund exclusively dedicated to healthcare software, has announced the acquisition of a majority stake in Medicore, a Netherlands-based provider of electronic patient and client records, and data-driven applications, for the healthcare sector.
In this HBI News Round up we cover one of India’s top for-profit hospital providers Aster DM Healthcare launching a new hospital project in India, the Ministry of Health in Spain restricting who can perform cosmetic surgeries, the UK’s second largest private ophthalmology group Optegra’s latest NHS eye clinic, Spanish for-profit hospital group Grupo Recoletas buying two new fertility clinics and Dutch-African CarePay raising €10 million to expand.
We also look at French drugmaker Sanofi receiving two bids for its consumer health unit, PE firm LeapFrog investing $120-30 million in India’s healthcare and Bulgarian courts overturning healthcare regulations.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy